FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Drorit Neumann

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Genes & Molecular Sequences

Amino Acid Sequences

Disorders

Co-author Network

Publications

TOP 3
Howard S Oster; Sara Prutchi-Sagiv; Esther Shabtai; Ora Halutz; Michael Hoffman; Drorit Neumann; Moshe Mittelman
Erythropoietin treatment is associated with an augmented immune response to the influenza vaccine in hematologic patients.
D Inbar; Malka Cohen-Armon; Drorit Neumann
Erythropoietin-driven signalling and cell migration mediated by polyADP-ribosylation.
Liron Yosha; Orly Ravid; Nathalie Ben-Califa; Drorit Neumann
Cytosolic lysine residues enhance anterograde transport and activation of the erythropoietin receptor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Drorit Neumann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Howard S Oster; Sara Prutchi-Sagiv; Esther Shabtai; Ora Halutz; Michael Hoffman; Drorit Neumann; Moshe Mittelman
Erythropoietin treatment is associated with an augmented immune response to the influenza vaccine in hematologic patients.
Experimental hematology 2013;41(2):167-71.
2012: D Inbar; Malka Cohen-Armon; Drorit Neumann
Erythropoietin-driven signalling and cell migration mediated by polyADP-ribosylation.
British journal of cancer 2012;107(8):1317-26.
2011: Liron Yosha; Orly Ravid; Nathalie Ben-Califa; Drorit Neumann
Cytosolic lysine residues enhance anterograde transport and activation of the erythropoietin receptor.
The Biochemical journal 2011;435(2):509-18.
2010: Lilach Lifshitz; Galit Tabak; Max Gassmann; Moshe Mittelman; Drorit Neumann
Macrophages as novel target cells for erythropoietin.
Haematologica 2010;95(11):1823-31.
2010: Tamar Liron; Tal Nahari; Miriam C Souroujon; Drorit Neumann
Insertion of an NPVY sequence into the cytosolic domain of the erythropoietin receptor selectively affects erythropoietin-mediated signalling and function.
The Biochemical journal 2010;427(2):305-12.
2010: Odelia Katz; Matthew Stuible; Nathalia Golishevski; Lilach Lifshitz; Michel L Tremblay; Max Gassmann; Moshe Mittelman; Drorit Neumann
Erythropoietin treatment leads to reduced blood glucose levels and body mass: insights from murine models.
The Journal of endocrinology 2010;205(1):87-95.
2010: Lilach Lifshitz; Assaf Berger; Moshe Mittelman; Drorit Neumann
Erythropoietin and cyclophosphamide combination treatment additively enhances antibody production in mice.
Acta haematologica 2010;123(2):81-3.
2009: Maayan Avneon; Lilach Lifshitz; Odelia Katz; Sara Prutchi-Sagiv; Max Gassmann; Moshe Mittelman; Drorit Neumann
Non-erythroid effects of erythropoietin: are neutrophils a target?
Leukemia research 2009;33(10):1430-2.
2009: Ashgan Bishara; Amira Rudi; Israel Goldberg; Maurice Aknin; Drorit Neumann; Nathalie Ben-Califa; Yoel Kashman
Tausalarin C: a new bioactive marine sponge-derived nitrogenous bismacrolide.
Organic letters 2009;11(16):3538-41.
2009: Lilach Lifshitz; Sara Prutchi-Sagiv; Maayan Avneon; Max Gassmann; Moshe Mittelman; Drorit Neumann
Non-erythroid activities of erythropoietin: Functional effects on murine dendritic cells.
Molecular immunology 2009;46(4):713-21.
2008: Sara Prutchi Sagiv; Lilach Lifshitz; Ruth Orkin; Moshe Mittelman; Drorit Neumann
Erythropoietin effects on dendritic cells: potential mediators in its function as an immunomodulator?
Experimental hematology 2008;36(12):1682-90.
2008: Ashgan Bishara; Amira Rudi; Maurice Aknin; Drorit Neumann; Nathalie Ben-Califa; Yoel Kashman
Taumycins A and B, two bioactive lipodepsipeptides from the Madagascar sponge Fascaplysinopsis sp.
Organic letters 2008;10(19):4307-9.
2008: Tal Nahari; Eran Barzilay; Koret Hirschberg; Drorit Neumann
A transplanted NPVY sequence in the cytosolic domain of the erythropoietin receptor enhances maturation.
The Biochemical journal 2008;410(2):409-16.
2008: Ashgan Bishara; Amira Rudi; Maurice Aknin; Drorit Neumann; Nathalie Ben-Califa; Yoel Kashman
Salarins a and B and tulearin a: new cytotoxic sponge-derived macrolides.
Organic letters 2008;10(2):153-6.
2007: Orly Ravid; Imad Shams; Nathalie Ben-Califa; Eviatar Nevo; Aaron Avivi; Drorit Neumann
An extracellular region of the erythropoietin receptor of the subterranean blind mole rat Spalax enhances receptor maturation.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(36):14360-5.
2007: Hagit Sorek; Amira Rudi; Yehuda Benayahu; Nathalie Ben-Califa; Drorit Neumann; Yoel Kashman
Nuttingins A-F and malonganenones D-H, tetraprenylated alkaloids from the Tanzanian gorgonian Euplexaura nuttingi.
Journal of natural products 2007;70(7):1104-9.
2007: Odelia Katz; Lidor Gil; Lilach Lifshitz; Sara Prutchi-Sagiv; Max Gassmann; Moshe Mittelman; Drorit Neumann
Erythropoietin enhances immune responses in mice.
European journal of immunology 2007;37(6):1584-93.
2006: Sara Prutchi-Sagiv; Natalia Golishevsky; Howard S Oster; Odelia Katz; Amos Cohen; Elizabeth Naparstek; Drorit Neumann; Moshe Mittelman
Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease?
British journal of haematology 2006;135(5):660-72.
2006: Howard S Oster; Michael Hoffman; Sara Prutchi-Sagiv; Odelia Katz; Drorit Neumann; Moshe Mittelman
Erythropoietin in clinical practice: current use, effect on survival, and future directions.
The Israel Medical Association journal : IMAJ 2006;8(10):703-6.
2005: Eran Barzilay; Nathalie Ben-Califa; Koret Hirschberg; Drorit Neumann
Uncoupling of brefeldin a-mediated coatomer protein complex-I dissociation from Golgi redistribution.
Traffic (Copenhagen, Denmark) 2005;6(9):794-802.
2005: Eran Barzilay; Nathalie Ben-Califa; Mika Shahar; Yoel Kashman; Drorit Neumann
Generation of a novel anti-geldanamycin antibody.
Biochemical and biophysical research communications 2005;330(2):561-4.
2005: Odelia Katz; Eran Barzilay; Alon Skaat; Arie Herman; Moshe Mittelman; Drorit Neumann
Erythropoietin induced tumour mass reduction in murine lymphoproliferative models.
Acta haematologica 2005;114(3):177-9.
2004: Moshe Mittelman; Aliza Zeidman; Pazit Kanter; Odelia Katz; Howard S Oster; Debbora Rund; Drorit Neumann
Erythropoietin has an anti-myeloma effect - a hypothesis based on a clinical observation supported by animal studies.
European journal of haematology 2004;72(3):155-65.
2004: Eran Barzilay; Nathalie Ben-Califa; Lia Supino-Rosin; Yoel Kashman; Koret Hirschberg; Zvulun Elazar; Drorit Neumann
Geldanamycin-associated inhibition of intracellular trafficking is attributed to a co-purified activity.
The Journal of biological chemistry 2004;279(8):6847-52.
2004: Jacob Cohen; Liat Oren-Young; Ursula Klingmuller; Drorit Neumann
Protein tyrosine phosphatase 1B participates in the down-regulation of erythropoietin receptor signalling.
The Biochemical journal 2004;377(Pt 2):517-24.
2002: Jacob Cohen; Lia Supino-Rosin; Eran Barzilay; Ronit Eisen-Lev; Moshe Mittelman; Drorit Neumann
Erythropoietin and its receptor: signaling and clinical manifestations.
The Israel Medical Association journal : IMAJ 2002;4(11):1072-6.
2002: Galit Flint-Ashtamker; Ronit Eisen-Lev; Jacob Cohen; Lily Jun-shen Huang; Drorit Neumann
Amino acid residues 268-276 of the erythropoietin receptor contain an endocytosis motif and are required for erythropoietin-mediated proliferation.
FEBS letters 2002;518(1-3):189-94.
2001: Moshe Mittelman; Drorit Neumann; A Peled; Pazit Kanter; Nechama Haran-Ghera
Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(9):5181-6.
2000: Lia Supino-Rosin; Akihiko Yoshimura; Y Yarden; Zvulun Elazar; Drorit Neumann
Intracellular retention and degradation of the epidermal growth factor receptor, two distinct processes mediated by benzoquinone ansamycins.
The Journal of biological chemistry 2000;275(29):21850-5.
1999: Lia Supino-Rosin; Akihiko Yoshimura; H Altaratz; Drorit Neumann
A cytosolic domain of the erythropoietin receptor contributes to endoplasmic reticulum-associated degradation.
European journal of biochemistry / FEBS 1999;263(2):410-9.
1998: I Levin; Jacob Cohen; Lia Supino-Rosin; Akihiko Yoshimura; S S Watowich; Drorit Neumann
Identification of a cytoplasmic motif in the erythropoietin receptor required for receptor internalization.
FEBS letters 1998;427(2):164-70.
1997: Jacob Cohen; H Altaratz; Y Zick; U Klingmüller; Drorit Neumann
Phosphorylation of erythropoietin receptors in the endoplasmic reticulum by pervanadate-mediated inhibition of tyrosine phosphatases.
The Biochemical journal 1997;327 ( Pt 2)():391-7.
1996: Drorit Neumann; M H Yuk; Harvey Lodish; Gerardo Z Lederkremer
Blocking intracellular degradation of the erythropoietin and asialoglycoprotein receptors by calpain inhibitors does not result in the same increase in the levels of their membrane and secreted forms.
The Biochemical journal 1996;313 ( Pt 2)():391-9.
1993: Gregory D Longmore; PN Pharr; Drorit Neumann; Harvey Lodish
Both megakaryocytopoiesis and erythropoiesis are induced in mice infected with a retrovirus expressing an oncogenic erythropoietin receptor.
Blood 1993;82(8):2386-95.
1993: Gregory D Longmore; Stephanie S Watowich; PN Pharr; Drorit Neumann; Harvey Lodish
Activation of the erythropoietin receptor and leukemia induction in mice.
Leukemia 1993;7 Suppl 2():S113-6.
1993: Drorit Neumann; L Wikström; Stephanie S Watowich; Harvey Lodish
Intermediates in degradation of the erythropoietin receptor accumulate and are degraded in lysosomes.
The Journal of biological chemistry 1993;268(18):13639-49.
1993: H Youssoufian; Gregory D Longmore; Drorit Neumann; A Yoshimura; Harvey Lodish
Structure, function, and activation of the erythropoietin receptor.
Blood 1993;81(9):2223-36.
1992: Akihiko Yoshimura; Teresa Zimmers; Drorit Neumann; Gregory D Longmore; Y Yoshimura; Harvey Lodish
Mutations in the Trp-Ser-X-Trp-Ser motif of the erythropoietin receptor abolish processing, ligand binding, and activation of the receptor.
The Journal of biological chemistry 1992;267(16):11619-25.